ERBB2 and breast carcinoma: Furthermore, in a publicly available breast cancer patient dataset (GSE1456), SUSD2 expression levels were found to be upregulated in HER2+ breast cancer subtypes, including the luminal B and HER2 subtypes (Figure 2D).